25
Participants
Start Date
April 30, 2012
Primary Completion Date
November 30, 2014
Study Completion Date
November 30, 2014
BMN 110
Weekly IV infusions of BMN 110 at 2.0 mg/kg/week over a period of approximately 4 hours per infusion for up to 192 weeks.
BMN 110
Weekly IV infusions of BMN 110 at 4.0 mg/kg/week over a period of approximately 4 hours per infusion for 27 weeks, and will eventually transition to 2.0 mg/kg/week for up to an additional 166 weeks.
Oakland
Chicago
New York
Houston
Calgary
Toronto
Montreal
Sherbrook
Hamburg
Belfast
Manchester
Lead Sponsor
BioMarin Pharmaceutical
INDUSTRY